Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Micro
FDA Approves RAMELTEON — Micro Labs Limited

# FDA Approves Generic Ramelteon by Micro Labs Limited The FDA has approved Micro Labs Limited's generic version of Ramelteon (ANDA215243), an oral m...

AMNEAL
FDA Approves Unknown Drug — AMNEAL

# FDA Approves Amneal Generic Drug Application Amneal Pharmaceuticals received FDA approval for ANDA213562 on January 31, 2023, expanding its generic...

Stemline
FDA Approves ORSERDU — Stemline Therapeutics, Inc.

Stemline Therapeutics, Inc. announced on January 27, 2023, that the FDA approved its oral selective estrogen receptor degrader (SERD) Elacestrant unde...

Gland
FDA Approves KETAMINE HYDROCHLORIDE — Gland Pharma Limited

# FDA Approves Gland Pharma's Generic Ketamine Hydrochloride Injection Gland Pharma Limited received FDA approval for its generic ketamine hydrochlor...

ZYDUS
FDA Approves Unknown Drug — ZYDUS PHARMS

ZYDUS PHARMS secured an FDA approval for its generic application ANDA209655, positioning the company to capture future market share and increase thera...

TheracosBio,
FDA Approves BRENZAVVY — TheracosBio, LLC

TheracosBio, LLC received FDA approval for the oral diabetes agent BRENZAVVY, a milestone that establishes its presence in the competitive SGLT2 inhib...

Meitheal
FDA Approves NELARABINE — Meitheal Pharmaceuticals Inc

Meitheal Pharmaceuticals Inc. has secured FDA approval for NELARABINE (ANDA216038), signaling the company's entry into the oncology market and initiat...

ONESOURCE
FDA Approves MYCOPHENOLATE MOFETIL — ONESOURCE SPECIALTY PHARMA LIMITED

ONESOURCE SPECIALTY PHARMA LIMITED announced the approval of intravenous mycophenolate mofetil under ANDA 216390, which could strengthen the biologic ...

Gilead
FDA Approves SUNLENCA — Gilead Sciences, Inc.

# FDA Approves Gilead Sciences' SUNLENCA (lenacapavir sodium), a First-in-Class HIV Treatment Gilead Sciences, Inc. received FDA approval for SUNLENC...

Gilead
FDA Approves SUNLENCA — Gilead Sciences, Inc.

# FDA Approves Gilead Sciences' SUNLENCA (Lenacapavir Sodium) for HIV Treatment Gilead Sciences, Inc. received FDA approval for SUNLENCA (lenacapavir...

Apotex
FDA Approves BRIMONIDINE TARTRATE — Apotex Corp.

# FDA Approves Generic Brimonidine Tartrate from Apotex Corp. The FDA has approved Apotex Corp.'s abbreviated new drug application for generic brimon...

NorthStar
FDA Approves LEVOTHYROXINE SODIUM — NorthStar RxLLC

# FDA Approves NorthStar RxLLC's Generic Levothyroxine Sodium The U.S. Food and Drug Administration has approved NorthStar RxLLC's abbreviated new dr...

Mirati
FDA Approves KRAZATI — Mirati Therapeutics, Inc

Mirati Therapeutics, Inc. received FDA approval for its oral KRAS G12C inhibitor KRAZATI (adagrasib), a move that solidifies its position in a highly ...

Cycle
FDA Approves TASCENSO ODT — Cycle Pharmaceuticals Ltd

Cycle Pharmaceuticals Ltd announced the FDA approval of TASCENSO ODT (fingolimod lauryl sulfate), its new once-daily oral formulation for demyelinatin...

Ingenus
FDA Approves CARBAMAZEPINE — Ingenus Pharmaceuticals, LLC

Ingenus Pharmaceuticals, LLC announced FDA approval of its ANDA for oral carbamazepine tablets, fulfilling the need for a generic alternative to the w...

EPIC
FDA Approves OXCARBAZEPINE — EPIC PHARMA, LLC

On November 30, 2022, **Epic Pharma, LLC** announced the approval of its Abbreviated New Drug Application (ANDA) 215332 for OXCARBAZEPINE, ensuring co...

Aurobindo
FDA Approves CARBIDOPA AND LEVODOPA — Aurobindo Pharma Limited

Aurobindo Pharma Limited secured FDA approval for its generic Carbidopa and Levodopa oral tablet, positioning the company to capitalize on cost-sensit...

Provention
FDA Approves TZIELD — Provention Bio, Inc.

The FDA granted accelerated approval to Provention Bio’s TEPLIZUMAB-MZWV (TZIELD), a novel immunotherapy for type 1 diabetes, significantly bolstering...

Amneal
FDA Approves LEUPROLIDE ACETATE — Amneal Pharmaceuticals LLC

# FDA Approves Generic Leuprolide Acetate for Amneal Pharmaceuticals Amneal Pharmaceuticals LLC received FDA approval for its generic leuprolide acet...

Janssen
FDA Approves TECVAYLI — Janssen Biotech, Inc.

# FDA Approves Janssen Biotech's TECVAYLI for Multiple Myeloma Treatment The FDA has approved Janssen Biotech's TECVAYLI (teclistamab-cqyv), a subcut...